CardioExchange Archive

May 2nd, 2012

Real-World Experience with TAVI: Vive la France!

Richard A. Lange, MD, MBA and L. David Hillis, MD

A study of data from FRANCE 2, a prospectively maintained, multicenter registry of the French national experience with transcatheter aortic valve implantation (TAVI), has now been published in the New England Journal of Medicine. The registry captured every TAVI performed at all 34 active centers in France and Monaco; it therefore reflects “real-life” experience with TAVI in patients with […]

---

March 26th, 2012

PARTNER: TAVR Results Appear Durable at 2 Years

Larry Husten, PHD

Two-year results of the influential PARTNER trial provide continued support for the growing acceptance of transcatheter aortic valve replacement (TAVR) in clinical practice. Previously, results of PARTNER at 1 year had demonstrated similar mortality in high-risk patients with aortic stenosis who underwent TAVR or surgery. Now, the 2-year results have been presented at the American College of Cardiology […]

---

January 31st, 2012

Consensus Document Provides Roadmap to Uptake of TAVR in U.S.

Larry Husten, PHD

Following the recent FDA approval of transcatheter aortic valve replacement (TAVR), the ACC, AATS, SCAI, and STS — in conjunction with several other medical organizations — have released a critical consensus document to guide use of the new landmark procedure. “We have tried to collate the evidence into a coherent road map for judicious use, rational dispersion, […]

---

July 21st, 2011

Sapien Transcatheter Heart Valve Receives Strong Support from FDA Advisory Panel

Larry Husten, PHD

The FDA Circulatory Systems Devices Panel has given a strong vote of support in favor of the Sapien Transcatheter Heart Valve (THV) for use in patients with inoperable severe aortic stenosis and with no comorbidities precluding benefit from correction of the stenosis. By large majorities, the panel voted that the procedure was safe (7-3), that […]

---

April 11th, 2011

PARTNER A: An Investigator’s View

Michael Mack, M.D.

CardioExchange welcomes Dr. Michael Mack to discuss the results of the PARTNER study of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (AVR) in patients with aortic stenosis, which were just released at the ACC meetings in New Orleans. Dr. Mack was one of the principal investigators in this and the recently published […]

---